Mr. Naini joined Frazier Healthcare (www.frazierhealthcare.com) shortly after inception in 1991, and has been a General Partner and served on the firm's management committee since 1995. Mr. Naini leads the firm's growth equity investment practice and continues to selectively invest in late stage biopharma and medical device companies. Historically, he has been involved with several of the firm's biopharma investments, including CV Therapeutics (NASDAQ: CVTX), Tularik (NASDAQ: TLRK) and ZymoGenetics (NASDAQ: ZGEN). More recently, Mr. Naini was the chairman of the board of Aspen Education Group (www.aspeneducation.com) which was sold in November 2006 to Bain Capital sponsored CRC Corporation, and served on the board of CHG Healthcare Services which was sold in December 2006 to JW Childs. He currently serves on the boards of Bariatric Partners, Inc., Elder Health, La Jolla Pharmaceuticals (NASDAQ: LJPC), Priority Solutions, ppoNEXT, Pentec Health and ZONARE Medical Systems.

Prior to joining Frazier Healthcare, Mr. Naini was with Goldman Sachs & Co.; prior to that, he held a position as a researcher at the Wistar Institute. Mr. Naini received a bachelor of arts in molecular biology degree from the University of Pennsylvania, and a masters in business administration from the Leonard N. Stern School of Business at New York University.